Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$28.31
0.481.72%
Last update: 12:52 PM
15 minutes delayed
Comments
Loading...
Overview Rating
Good
Alkermes (NASDAQ:ALKS) Stock Quotes, Forecast and News Summary
Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
| Open | $28.26 |
| Close | - |
| Volume / Avg. | 357.44K / 1.78M |
| Day Range | $27.99 - $28.43 |
| 52 Wk Range | 22.01 - 32.88 |
| Market Cap | $4.66B |
| P/E Ratio | 12.21 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 60 |
| Short Interest | 15.44% |
| Days to Cover | 14.57 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Alkermes plc
Sector
Health Care
Industry
Biotechnology
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies t...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Alkermes (ALKS) stock?
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Who are Alkermes (ALKS) competitors?
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Alkermes (ALKS) stock?
Alkermes has a consensus price target of $34.63.
What is the current price for Alkermes (ALKS)?
The stock price for Alkermes (NASDAQ: ALKS) is $28.31 last updated September 19, 2024 at 12:52 PM EDT.
Does Alkermes (ALKS) pay a dividend?
There are no upcoming dividends for Alkermes.
When is Alkermes (NASDAQ:ALKS) reporting earnings?
Alkermes’s Q3 earnings are confirmed for Wednesday, October 23, 2024.
Is Alkermes (ALKS) going to split?
There is no upcoming split for Alkermes.
What sector and industry does Alkermes (ALKS) operate in?
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.